Abstract
The association of breast density (% of breast volume involved by fibro-glandular densities) with the risk of interval cancer (IC) was investigated by reviewing a consecutive series of 346 cancers detected at screening (SDC) during 1996–1999 and of 90 ICs, reported as negative in the same period and diagnosed in the following 2 years, and comparing them to a random sample of 360 healthy controls. The probability of IC was significantly associated with breast density, whatever grouping (0/1–25/26–74/>74%; 0–25/26–60/61–74/>74%; 0–25/26–74/>74%) was considered (χ2=30.67–34.08, P<0.<0.01): 27.8% of all ICs were classified in the >74% density class, as compared to 7% of SDC and 5% of healthy controls. No significant association to IC was observed for Wolfe pattern (P2/Dy vs N1/P1: χ2=0.30, P=0.960), number of used mammographic views (single oblique vs oblique+craniocaudal: χ2=0.02, P=0.90) or screening round (first vs repeat: χ2=1.41, P=0.23). Multivariate analysis confirmed the independent association of breast density to IC, the highest risk being observed for >74% density class (OR vs 0% class=13.4, 95% CI 2.7–65.6, OR vs all other density classes=5.1, 95% CI 2.6–10.0). Age showed an independent association too, older women having a lower risk of IC (OR=0.52 95% CI 0.3–09). Breast density (>74%) resulted as being a major determinant of IC. Special screening protocols (shorter rescreening interval, routine use of ultrasonography) might be suggested for these subjects in order to improve screening sensitivity and efficacy.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have